Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 3, 1998, Pages 269-273

  Fukao, Hideharu ^a   Matsuo, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Human umbilical vein endothelial cells; Plasminogen activator inhibitor 1; Tissue type plasminogen activator; Tissue type plasminogen activator receptor

Indexed keywords

CELL RECEPTOR; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; UMBILICAL VEIN;

EID: 0031819051     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995853     Document Type: Conference Paper

References (20)

1. Ny T, Elgh F, Lund B. The structure of the human tissue-type plasminogen activator gene: Correlation of intron and exon structure to functional and structural domains. Proc Natl Acad Sci USA 1984;81:5355-5359.
2. Holmes WE, Pennica D, Blaher M. Cloning and expression of the gene for pro-urokinase in Escherichia coli. Biotechnology 1995;3:923-928
3. Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980;43:77-89
4. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381-387
5. 2-antiplasmin, a serine protease inhibitor (serpin). J Biol Chem 1987;262:1659-1664
6. Fukao H, Ueshima S, Okada K, et al. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Thromb Res 1992;68:57-65
7. Plow EF, Freaney DE, Plescia J, Miles LA. The plasminogen system and cell surface: Evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 1986;103:2411-2420
8. Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Biol Chem 1990;110:155-163
9. Andronicos NM, Ranson M, Bognacki J, Baker MS. The human ENO1 gene product (recombinant human α-enolase) displays characteristics required for a plasminogen binding protein. Biochim Biophys Acta 1997;1337:27-39
10. Miles LA, Dahlberg CM, Plescia J, et al. Role of cell-surface lysines in plasminogen binding to cells. Identification of α-enolase as a candidate plasminogen receptor. Biochemistry 1991;30:1682-1691
11. Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995;227:407-415
12. Hembrough TA, Li L, Gonias SL. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem 1996;271:25684-25691
13. Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein (a). Br J Haematol 1996;95:168-178
14. Miles LA, Dahlberg CM, Levin E, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989;28:9337-9343
15. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II. J Biol Chem 1994;269:21191-21197
16. Cheng X-F, Pohl G, Back O, Wallen P. Characterization of receptors interacting specifically with the B-chain of tissue plasminogen activator on endothelial cells. Fibrinolysis 1996;10:167-175
17. Felez J, Chanquia CJ, Fabregas P, Plow EF, Miles LA. Competition between plasminogen and tissue plasminogen activator for cellular binding sites. Blood 1993;82:2433-2441
18. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA): II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994;269:21198-21203
19. Fukao H, Hagiya Y, Nonaka T, Okada K, Matsuo O. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells. Biochem Biophys Res Commun 1992;187: 956-962
20. Fukao H, Ueshima S, Takaishi T, Okada K, Matsuo O. Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells. Biochim Biophys Acta 1997;1356:111-120